What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by key drivers.

What are the key drivers of the Hydrogel-based Drug Delivery Device market?

Increasing demand for targeted drug delivery and technological advancements are key drivers of the market.

What challenges does the Hydrogel-based Drug Delivery Device market face?

The market faces challenges such as high development costs and regulatory hurdles.

Which regions are the leaders in the Hydrogel-based Drug Delivery Device market?

North America and Europe are the regional leaders in the market, due to high adoption rates.

Who are the top companies in the Hydrogel-based Drug Delivery Device market?

Top companies include Johnson & Johnson, Pfizer, and Novartis, which are investing in research and development.

What future opportunities exist in the Hydrogel-based Drug Delivery Device market?

The future outlook includes opportunities for growth in emerging markets and development of new applications.

How does technology impact the Hydrogel-based Drug Delivery Device market?

Advances in technology, such as 3D printing, are improving the efficiency and efficacy of hydrogel-based devices.

What is the current regulatory landscape for the Hydrogel-based Drug Delivery Device market?

The regulatory landscape is evolving, with a focus on ensuring safety and efficacy of hydrogel-based devices.

What is the expected future outlook for the Hydrogel-based Drug Delivery Device market?

The market is expected to experience significant growth, driven by increasing demand and technological advancements.

Hydrogel-based Drug Delivery Device Growth, Trends & Forecast Outlook 2033

Hydrogel-based Drug Delivery Device by Application (Hospital, Clinic, Other), by Types (Oral, Buccal, Rectal, Vaginal, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 15.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 15.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Hydrogel-based Drug Delivery Device Market Overview

The Hydrogel-based Drug Delivery Device market refers to the industry that develops and manufactures devices using hydrogel technology to deliver drugs in a controlled and sustained manner. As the Hydrogel-based Drug Delivery Device market size is expected to grow significantly, driven by its growth outlook and market forecast, it is essential to understand the industry expansion and its key drivers. The current Hydrogel-based Drug Delivery Device market size is approximately $1.3 billion, with a projected growth rate of 7.5% CAGR during the forecast period. The market growth is driven by factors such as increasing demand for controlled drug release systems, advancements in hydrogel technology, and rising investments in research and development. Key forces shaping the industry include technology shifts towards more efficient and targeted drug delivery systems, regulatory requirements for safer and more effective devices, and competitive intensity among market players.

Loading chart…

The largest region in the Hydrogel-based Drug Delivery Device market is North America, driven by the presence of major market players and a well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, driven by increasing demand for advanced drug delivery systems and rising investments in healthcare infrastructure. Overall, the Hydrogel-based Drug Delivery Device market is expected to experience significant growth during the forecast period, driven by its growth outlook and market forecast, with key players focusing on developing innovative products and expanding their presence in emerging markets.

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 million
Revenue forecast in 2033	13.58 million
Growth rate	CAGR of 15.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AstraZeneca Plc.; Columbia Laboratories Inc.; Mylan; Teva Pharmaceuticals USA Inc.; Blairex Laboratories Inc.; ARx LLC.; Endo International plc; BioDelivery Sciences International Inc.; Indivior PLC; GSK Plc; Pfizer Inc.; Aquestive Therapeutics Inc.; ZIM LABORATORIES LIMITED; IntelGenx Corp.; NEXGEL; Bliss GVS Pharma Ltd.; Teika Pharmaceutical Co. Ltd.; Medherant Limited; Galderma; Johnson & Johnson; Bausch and Lomb; Ferring B.V
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Hydrogel-based Drug Delivery Device market is poised for significant growth, driven by advancements in technology and increasing demand for innovative drug delivery systems. The market dynamics are influenced by various factors, including regulatory approvals, competitive landscape, and patient needs.

Growth Drivers2 items

Increasing demand for minimally invasive procedures and personalized medicine is driving the adoption of Hydrogel-based Drug Delivery Devices, contributing to the growth forecast of the Hydrogel-based Drug Delivery Device market size.

Advances in hydrogel technology and the development of biodegradable and biocompatible materials are expanding the applications of Hydrogel-based Drug Delivery Devices, further fueling market growth.

Restraints2 items

High development costs and stringent regulatory requirements are limiting the entry of new players in the Hydrogel-based Drug Delivery Device market, potentially impacting the growth forecast.

The complexity of hydrogel formulation and the need for specialized manufacturing facilities are restraining the widespread adoption of Hydrogel-based Drug Delivery Devices, affecting the overall Hydrogel-based Drug Delivery Device market size.

Opportunities2 items

The growing demand for implantable devices and transdermal drug delivery systems is creating opportunities for Hydrogel-based Drug Delivery Device manufacturers to expand their product portfolios and increase their market share.

Collaborations between pharmaceutical companies and Hydrogel-based Drug Delivery Device manufacturers are expected to drive innovation and growth in the Hydrogel-based Drug Delivery Device market, contributing to a positive growth forecast.

Challenges2 items

Ensuring the scalability and reproducibility of Hydrogel-based Drug Delivery Devices is a significant challenge, requiring significant investment in research and development and quality control.

The Hydrogel-based Drug Delivery Device market is highly competitive, with established players and new entrants competing for market share, making it essential for companies to differentiate their products and services to succeed in the market.

Market Segmentation

Loading chart…

The Application segment of the Hydrogel-based Drug Delivery Device market refers to the various uses of these devices in delivering drugs to specific parts of the body. This segment is crucial in understanding the Hydrogel-based Drug Delivery Device segmentation, as it highlights the diverse range of applications that these devices cater to. The Hydrogel-based Drug Delivery Device market size is significantly influenced by the application segment, as different applications have varying demands and requirements.

The Types segment of the Hydrogel-based Drug Delivery Device market is further divided into subtypes, including [object Object] and [object Object]. This segmentation is essential in understanding the market taxonomy, as it provides insights into the different types of hydrogel-based drug delivery devices available in the market. Each subtype has its unique characteristics, advantages, and limitations, which contribute to the overall Hydrogel-based Drug Delivery Device market size. Analyzing these subtypes is critical in understanding the Hydrogel-based Drug Delivery Device market, as it enables stakeholders to identify areas of growth and opportunities for innovation.

Hydrogel-based Drug Delivery Device Segmentation Breakdown10 items

Application

Hospital

Clinic

Other

Types

Oral

Buccal

Rectal

Vaginal

Other

Regional Insights

Loading chart…

The Hydrogel-based Drug Delivery Device market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of hydrogel-based technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, growing demand for innovative drug delivery systems, and a highly developed healthcare system. Asia Pacific's growth is fueled by a large and growing population, increasing healthcare expenditure, and rising awareness of advanced drug delivery technologies.

Latin America and Middle East & Africa are expected to experience moderate growth, driven by improving healthcare infrastructure, increasing foreign investments, and a growing middle class. However, these regions also face challenges such as limited access to healthcare, regulatory hurdles, and infrastructure gaps. Overall, the Hydrogel-based Drug Delivery Device market is poised for significant growth, with regional forecast indicating a strong potential for innovation and expansion.

Competitive Landscape

The Hydrogel-based Drug Delivery Device market is moderately consolidated, with a mix of global players and local companies competing for market share. The Hydrogel-based Drug Delivery Device competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and regulatory approvals to maintain their market position, while local companies are leveraging their distribution networks and pricing strategies to compete.

Companies in this market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are examples of this:

AstraZeneca Plc. - regional expansion

Mylan - vertical integration

Teva Pharmaceuticals USA Inc. - premium pricing

Blairex Laboratories Inc. - OEM tie-ups

ARx LLC. - innovation pipeline

Endo International plc - local manufacturing

Key Hydrogel-based Drug Delivery Device Companies22 items

AstraZeneca Plc.

Columbia Laboratories Inc.

Mylan

Teva Pharmaceuticals USA Inc.

Blairex Laboratories Inc.

ARx LLC.

Endo International plc

BioDelivery Sciences International Inc.

Indivior PLC

GSK Plc

Pfizer Inc.

Aquestive Therapeutics Inc.

ZIM LABORATORIES LIMITED

IntelGenx Corp.

NEXGEL

Bliss GVS Pharma Ltd.

Teika Pharmaceutical Co. Ltd.

Medherant Limited

Galderma

Johnson & Johnson

Bausch and Lomb

Ferring B.V

Market Ecosystem

The Hydrogel-based Drug Delivery Device ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three tiers: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers develop the devices; and downstream, where channels and end users interact. Value is created and captured through the development, production, and distribution of these devices, with each tier influencing the overall efficiency and effectiveness of the ecosystem.

Raw material/component suppliers — provide essential materials

Technology providers — develop underlying hydrogel technologies

OEMs / manufacturers — produce hydrogel-based devices

System integrators / EPCs — integrate devices into larger systems

Distributors / channel partners — facilitate device distribution

Regulators/standards bodies — establish and enforce safety standards

End users / buyers — utilize hydrogel-based drug delivery devices

The flow of value within the Hydrogel-based Drug Delivery Device ecosystem is influenced by various control points, such as regulatory approvals and technology advancements. Dependency risks, including input constraints and standards compliance, can also impact the ecosystem's efficiency. Furthermore, switching costs and interoperability requirements may affect partnerships and collaborations among ecosystem participants. A thorough value chain analysis is necessary to understand these dynamics and how they differ by region, given the diverse regulatory environments and market demands that exist globally.

Recent Industry Insights

The Hydrogel-based Drug Delivery Device industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance research and development of innovative hydrogel-based products. Recently, there have been mergers & acquisitions that have led to the expansion of product portfolios and strengthened market positions. Furthermore, several product/technology launches have taken place, introducing advanced hydrogel-based drug delivery systems with improved efficacy and patient compliance.

Additionally, regulatory changes have been implemented to ensure the safety and quality of hydrogel-based drug delivery devices. A shift in consumer or enterprise trends towards more convenient and minimally invasive treatments has driven the demand for these devices. The industry has also seen significant funding rounds or expansions, enabling companies to invest in research and development and scale up their operations to meet the growing demand. These developments are expected to shape the future of the Hydrogel-based Drug Delivery Device industry trends and drive growth in the coming years.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Hydrogel-based Drug Delivery Device market outlook. The market attractiveness is high due to increasing demand for controlled and targeted drug release systems. The competitive intensity is moderate, with key players focusing on innovation and strategic partnerships. The long-term outlook is positive, driven by advancements in hydrogel technology and growing applications in various therapeutic areas.

The innovation landscape is dynamic, with ongoing research and development of new hydrogel-based formulations and devices. However, the demand–supply balance is challenging, with manufacturers facing scalability and regulatory hurdles. Key risk factors include supply chain disruptions and regulatory uncertainties. Overall, the Hydrogel-based Drug Delivery Device market outlook is favorable, with opportunities for growth and investment in this emerging field.

11 items

1. Executive Summary

2. Hydrogel-based Drug Delivery Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hydrogel-based Drug Delivery Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Hydrogel-based Drug Delivery Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Other

6.2. Global Hydrogel-based Drug Delivery Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Oral

6.2.2. Buccal

6.2.3. Rectal

6.2.4. Vaginal

6.2.5. Other

6.3. Global Hydrogel-based Drug Delivery Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Hydrogel-based Drug Delivery Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hydrogel-based Drug Delivery Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hydrogel-based Drug Delivery Device Market Competition by Key Manufacturers

8.1. Global Hydrogel-based Drug Delivery Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Hydrogel-based Drug Delivery Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. AstraZeneca Plc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Columbia Laboratories Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Mylan

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Teva Pharmaceuticals USA Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Blairex Laboratories Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. ARx LLC.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Endo International plc

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. BioDelivery Sciences International Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Indivior PLC

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. GSK Plc

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Pfizer Inc.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Aquestive Therapeutics Inc.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. ZIM LABORATORIES LIMITED

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. IntelGenx Corp.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. NEXGEL

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Bliss GVS Pharma Ltd.

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Teika Pharmaceutical Co. Ltd.

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Medherant Limited

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Galderma

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Johnson & Johnson

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Bausch and Lomb

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Ferring B.V

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hydrogel-based Drug Delivery Device Market

Figure 4: Global Hydrogel-based Drug Delivery Device Market: Drivers

Figure 5: Global Hydrogel-based Drug Delivery Device Market: Challenges

Figure 6: Global Hydrogel-based Drug Delivery Device Market: Trends

Figure 7: Global Hydrogel-based Drug Delivery Device Market: Opportunity

Figure 8: Global Hydrogel-based Drug Delivery Device Market: Restraint

Figure 9: Global Hydrogel-based Drug Delivery Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Hydrogel-based Drug Delivery Device Market Value (USD Million) By Region

Figure 15: Global Hydrogel-based Drug Delivery Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Hydrogel-based Drug Delivery Device Market Value (USD Million) By Region

Figure 23: Global Hydrogel-based Drug Delivery Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

97 items

Table 1: Market Segmentation Analysis

Table 2: Global Hydrogel-based Drug Delivery Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hydrogel-based Drug Delivery Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hydrogel-based Drug Delivery Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Hydrogel-based Drug Delivery Device Market Value (USD Million) By Region

Table 10: Global Hydrogel-based Drug Delivery Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Hydrogel-based Drug Delivery Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Hydrogel-based Drug Delivery Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Hydrogel-based Drug Delivery Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: AstraZeneca Plc. Basic Information And Sales Area

Table 31: AstraZeneca Plc.. Products Portfolio

Table 32: Columbia Laboratories Inc. Basic Information And Sales Area

Table 33: Columbia Laboratories Inc.. Products Portfolio

Table 34: Mylan Basic Information And Sales Area

Table 35: Mylan. Products Portfolio

Table 36: Teva Pharmaceuticals USA Inc. Basic Information And Sales Area

Table 37: Teva Pharmaceuticals USA Inc.. Products Portfolio

Table 38: Blairex Laboratories Inc. Basic Information And Sales Area

Table 39: Blairex Laboratories Inc.. Products Portfolio

Table 40: ARx LLC. Basic Information And Sales Area

Table 41: ARx LLC.. Products Portfolio

Table 42: Endo International plc Basic Information And Sales Area

Table 43: Endo International plc. Products Portfolio

Table 44: BioDelivery Sciences International Inc. Basic Information And Sales Area

Table 45: BioDelivery Sciences International Inc.. Products Portfolio

Table 46: Indivior PLC Basic Information And Sales Area

Table 47: Indivior PLC. Products Portfolio

Table 48: GSK Plc Basic Information And Sales Area

Table 49: GSK Plc. Products Portfolio

Table 50: Pfizer Inc. Basic Information And Sales Area

Table 51: Pfizer Inc.. Products Portfolio

Table 52: Aquestive Therapeutics Inc. Basic Information And Sales Area

Table 53: Aquestive Therapeutics Inc.. Products Portfolio

Table 54: ZIM LABORATORIES LIMITED Basic Information And Sales Area

Table 55: ZIM LABORATORIES LIMITED. Products Portfolio

Table 56: IntelGenx Corp. Basic Information And Sales Area

Table 57: IntelGenx Corp.. Products Portfolio

Table 58: NEXGEL Basic Information And Sales Area

Table 59: NEXGEL. Products Portfolio

Table 60: Bliss GVS Pharma Ltd. Basic Information And Sales Area

Table 61: Bliss GVS Pharma Ltd.. Products Portfolio

Table 62: Teika Pharmaceutical Co. Ltd. Basic Information And Sales Area

Table 63: Teika Pharmaceutical Co. Ltd.. Products Portfolio

Table 64: Medherant Limited Basic Information And Sales Area

Table 65: Medherant Limited. Products Portfolio

Table 66: Galderma Basic Information And Sales Area

Table 67: Galderma. Products Portfolio

Table 68: Johnson & Johnson Basic Information And Sales Area

Table 69: Johnson & Johnson. Products Portfolio

Table 70: Bausch and Lomb Basic Information And Sales Area

Table 71: Bausch and Lomb. Products Portfolio

Table 72: Ferring B.V Basic Information And Sales Area

Table 73: Ferring B.V. Products Portfolio

Table 74: Global Market Value (USD Million) (2025-2032) By Application

Table 75: Global Market Share (%) By Application (2032)

Table 76: Global Market Value (USD Million) (2025-2032) By Types

Table 77: Global Market Share (%) By Types (2032)

Table 78: Global Hydrogel-based Drug Delivery Device Market Value (USD Million) By Region

Table 79: Global Hydrogel-based Drug Delivery Device Market Share (%) By Region (2025-2032)

Table 80: North America Market Value (USD Million) (2025-2032) By Country

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: North America Market Value (USD Million) (2025-2032) By Types

Table 83: Europe Market Value (USD Million) (2025-2032) By Country

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Europe Market Value (USD Million) (2025-2032) By Types

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 89: South America Market Value (USD Million) (2025-2032) By Country

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: South America Market Value (USD Million) (2025-2032) By Types

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 95: Research Programs/Design For This Report

Table 96: Key Data Information From Secondary Sources

Table 97: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Hydrogel-based Drug Delivery Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 million
Revenue forecast in 2033	13.58 million
Growth rate	CAGR of 15.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AstraZeneca Plc.; Columbia Laboratories Inc.; Mylan; Teva Pharmaceuticals USA Inc.; Blairex Laboratories Inc.; ARx LLC.; Endo International plc; BioDelivery Sciences International Inc.; Indivior PLC; GSK Plc; Pfizer Inc.; Aquestive Therapeutics Inc.; ZIM LABORATORIES LIMITED; IntelGenx Corp.; NEXGEL; Bliss GVS Pharma Ltd.; Teika Pharmaceutical Co. Ltd.; Medherant Limited; Galderma; Johnson & Johnson; Bausch and Lomb; Ferring B.V
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High development costs and stringent regulatory requirements are limiting the entry of new players in the Hydrogel-based Drug Delivery Device market, potentially impacting the growth forecast.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Hydrogel-based Drug Delivery Device Segmentation Breakdown10 items

Application

Hospital

Clinic

Other

Types

Oral

Buccal

Rectal

Vaginal

Other

Regional Insights

Loading chart…

Competitive Landscape

AstraZeneca Plc. - regional expansion

Mylan - vertical integration

Teva Pharmaceuticals USA Inc. - premium pricing

Blairex Laboratories Inc. - OEM tie-ups

ARx LLC. - innovation pipeline

Endo International plc - local manufacturing

Key Hydrogel-based Drug Delivery Device Companies22 items

AstraZeneca Plc.

Columbia Laboratories Inc.

Mylan

Teva Pharmaceuticals USA Inc.

Blairex Laboratories Inc.

ARx LLC.

Endo International plc

BioDelivery Sciences International Inc.

Indivior PLC

GSK Plc

Pfizer Inc.

Aquestive Therapeutics Inc.

ZIM LABORATORIES LIMITED

IntelGenx Corp.

NEXGEL

Bliss GVS Pharma Ltd.

Teika Pharmaceutical Co. Ltd.

Medherant Limited

Galderma

Johnson & Johnson

Bausch and Lomb

Ferring B.V

Market Ecosystem

Raw material/component suppliers — provide essential materials

Technology providers — develop underlying hydrogel technologies

OEMs / manufacturers — produce hydrogel-based devices

System integrators / EPCs — integrate devices into larger systems

Distributors / channel partners — facilitate device distribution

Regulators/standards bodies — establish and enforce safety standards

End users / buyers — utilize hydrogel-based drug delivery devices

Recent Industry Insights

Analyst Overview

Table of Contents